Nevertheless, our study represents the first investigation into the levels of anti-C3aR and anti-C5aR antibodies in glomerular diseases, revealing an association between the clinical development of lupus nephropathy and focal and segmental glomerulosclerosis and antibody levels. The gene discussed is C5AR1; the disease is glomerular disorder.